CLINICAL_TRIALS
trial_result
· 2020-11-19
Clinical Trial Update: Imiquimod for Preventing Keloid Recurrence [Phase 2]
Summary
Phase 2 clinical trial on imiquimod for preventing keloid recurrence has been terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pennsylvania | Conditions: Keloid | Phase 2 | Status: TERMINATED | Results posted: 2020-11-19